Therapeutic strategies for congenital myasthenic syndromes
To date, more than 25 genes have been implicated in the etiology of the congenital myasthenic syndromes (CMS), and an ever-growing phenotypic landscape is now encountered in the CMS clinic. Unlike the autoimmune form of myasthenia, there is no role for immunomodulatory agents in the treatment of CMS...
المؤلفون الرئيسيون: | Lee, M, Beeson, D, Palace, J |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Wiley
2018
|
مواد مشابهة
-
The congenital myasthenic syndromes.
حسب: Palace, J, وآخرون
منشور في: (2008) -
Congenital myasthenic syndromes.
حسب: Beeson, D, وآخرون
منشور في: (1997) -
Congenital myasthenic syndromes: an update.
حسب: Finlayson, S, وآخرون
منشور في: (2013) -
Congenital myasthenic syndromes and the neuromuscular junction.
حسب: Cruz, P, وآخرون
منشور في: (2014) -
The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
حسب: Rodríguez Cruz, P, وآخرون
منشور في: (2018)